APO Research

APO RESEARCH · REPORT

PRP (Platelet-Rich Plasma) Kits

Selected research

Market Structure

Global PRP (Platelet-Rich Plasma) Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global PRP (Platelet-Rich Plasma) Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PRP (Platelet-Rich Plasma) Kits include AdvaCare Pharma, Companion (Enovis), Dr. PRP USA, EmCyte, Enso Discoveries, Estar Medical, Fidia Farmaceutici, Juventix Regenerative Medical and Plasma Fresh, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global PRP (Platelet-Rich Plasma) Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PRP (Platelet-Rich Plasma) Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PRP (Platelet-Rich Plasma) Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PRP (Platelet-Rich Plasma) Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

PRP (Platelet-Rich Plasma) Kits Segment by Company

AdvaCare Pharma

Companion (Enovis)

Dr. PRP USA

EmCyte

Enso Discoveries

Estar Medical

Fidia Farmaceutici

Juventix Regenerative Medical

Plasma Fresh

PRP PURE

Refine USA

Regen Lab SA

Beijing Hanbaihan Medical Devices

Beijing Chunlizhengda Medical Instruments

Longtime Biological

WEGO

PRP (Platelet-Rich Plasma) Kits Segment by Type

Class II Medical Device

Class I Medical Device

PRP (Platelet-Rich Plasma) Kits Segment by Application

Medical

Laboratory

Others

PRP (Platelet-Rich Plasma) Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PRP (Platelet-Rich Plasma) Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PRP (Platelet-Rich Plasma) Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PRP (Platelet-Rich Plasma) Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PRP (Platelet-Rich Plasma) Kits market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PRP (Platelet-Rich Plasma) Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of PRP (Platelet-Rich Plasma) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of PRP (Platelet-Rich Plasma) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. PRP (Platelet-Rich Plasma) Kits Industry Trends Table 2. PRP (Platelet-Rich Plasma) Kits Industry Drivers Table 3. PRP (Platelet-Rich Plasma) Kits Industry Opportunities and Challenges Table 4. PRP (Platelet-Rich Plasma) Kits Industry Restraints Table 5. Global PRP (Platelet-Rich Plasma) Kits Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Manufacturers (2021-2026) Table 7. Global PRP (Platelet-Rich Plasma) Kits Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Manufacturers Table 9. Global PRP (Platelet-Rich Plasma) Kits Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global PRP (Platelet-Rich Plasma) Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global PRP (Platelet-Rich Plasma) Kits Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global PRP (Platelet-Rich Plasma) Kits Manufacturers, Product Type & Application Table 13. Global PRP (Platelet-Rich Plasma) Kits Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global PRP (Platelet-Rich Plasma) Kits by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Class II Medical Device Table 17. Major Manufacturers of Class I Medical Device Table 18. Global PRP (Platelet-Rich Plasma) Kits Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global PRP (Platelet-Rich Plasma) Kits Sales by Type (2021-2026) & (K Units) Table 20. Global PRP (Platelet-Rich Plasma) Kits Sales by Type (2027-2032) & (K Units) Table 21. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Type (2021-2026) Table 22. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Type (2027-2032) Table 23. Global PRP (Platelet-Rich Plasma) Kits Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global PRP (Platelet-Rich Plasma) Kits Revenue by Type (2021-2026) & (K Units) Table 25. Global PRP (Platelet-Rich Plasma) Kits Revenue by Type (2027-2032) & (K Units) Table 26. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Type (2021-2026) Table 27. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Medical Table 29. Major Manufacturers of Laboratory Table 30. Major Manufacturers of Others Table 31. Global PRP (Platelet-Rich Plasma) Kits Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global PRP (Platelet-Rich Plasma) Kits Sales by Application (2021-2026) & (K Units) Table 33. Global PRP (Platelet-Rich Plasma) Kits Sales by Application (2027-2032) & (K Units) Table 34. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Application (2021-2026) Table 35. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Application (2027-2032) Table 36. Global PRP (Platelet-Rich Plasma) Kits Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global PRP (Platelet-Rich Plasma) Kits Revenue by Application (2021-2026) & (K Units) Table 38. Global PRP (Platelet-Rich Plasma) Kits Revenue by Application (2027-2032) & (K Units) Table 39. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Application (2021-2026) Table 40. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Application (2027-2032) Table 41. Global PRP (Platelet-Rich Plasma) Kits Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global PRP (Platelet-Rich Plasma) Kits Sales by Region (2021-2026) & (K Units) Table 43. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Region (2021-2026) Table 44. Global PRP (Platelet-Rich Plasma) Kits Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global PRP (Platelet-Rich Plasma) Kits Sales Forecasted Market Share by Region (2027-2032) Table 46. North America PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2026) & (K Units) Table 48. North America PRP (Platelet-Rich Plasma) Kits Sales by Country (2027-2032) & (K Units) Table 49. Europe PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2026) & (K Units) Table 51. Europe PRP (Platelet-Rich Plasma) Kits Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales by Country (2027-2032) & (K Units) Table 58. Global PRP (Platelet-Rich Plasma) Kits Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global PRP (Platelet-Rich Plasma) Kits Revenue by Region (2021-2026) & (US$ Million) Table 60. Global PRP (Platelet-Rich Plasma) Kits Revenue by Region (2027-2032) & (US$ Million) Table 61. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Region (2021-2026) Table 62. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Region (2027-2032) Table 63. AdvaCare Pharma Company Information Table 64. AdvaCare Pharma Business Overview Table 65. AdvaCare Pharma PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AdvaCare Pharma PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 67. AdvaCare Pharma Recent Development Table 68. Companion (Enovis) Company Information Table 69. Companion (Enovis) Business Overview Table 70. Companion (Enovis) PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Companion (Enovis) PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 72. Companion (Enovis) Recent Development Table 73. Dr. PRP USA Company Information Table 74. Dr. PRP USA Business Overview Table 75. Dr. PRP USA PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Dr. PRP USA PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 77. Dr. PRP USA Recent Development Table 78. EmCyte Company Information Table 79. EmCyte Business Overview Table 80. EmCyte PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. EmCyte PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 82. EmCyte Recent Development Table 83. Enso Discoveries Company Information Table 84. Enso Discoveries Business Overview Table 85. Enso Discoveries PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Enso Discoveries PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 87. Enso Discoveries Recent Development Table 88. Estar Medical Company Information Table 89. Estar Medical Business Overview Table 90. Estar Medical PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Estar Medical PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 92. Estar Medical Recent Development Table 93. Fidia Farmaceutici Company Information Table 94. Fidia Farmaceutici Business Overview Table 95. Fidia Farmaceutici PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Fidia Farmaceutici PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 97. Fidia Farmaceutici Recent Development Table 98. Juventix Regenerative Medical Company Information Table 99. Juventix Regenerative Medical Business Overview Table 100. Juventix Regenerative Medical PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Juventix Regenerative Medical PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 102. Juventix Regenerative Medical Recent Development Table 103. Plasma Fresh Company Information Table 104. Plasma Fresh Business Overview Table 105. Plasma Fresh PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Plasma Fresh PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 107. Plasma Fresh Recent Development Table 108. PRP PURE Company Information Table 109. PRP PURE Business Overview Table 110. PRP PURE PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. PRP PURE PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 112. PRP PURE Recent Development Table 113. Refine USA Company Information Table 114. Refine USA Business Overview Table 115. Refine USA PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Refine USA PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 117. Refine USA Recent Development Table 118. Regen Lab SA Company Information Table 119. Regen Lab SA Business Overview Table 120. Regen Lab SA PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Regen Lab SA PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 122. Regen Lab SA Recent Development Table 123. Beijing Hanbaihan Medical Devices Company Information Table 124. Beijing Hanbaihan Medical Devices Business Overview Table 125. Beijing Hanbaihan Medical Devices PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Beijing Hanbaihan Medical Devices PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 127. Beijing Hanbaihan Medical Devices Recent Development Table 128. Beijing Chunlizhengda Medical Instruments Company Information Table 129. Beijing Chunlizhengda Medical Instruments Business Overview Table 130. Beijing Chunlizhengda Medical Instruments PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Beijing Chunlizhengda Medical Instruments PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 132. Beijing Chunlizhengda Medical Instruments Recent Development Table 133. Longtime Biological Company Information Table 134. Longtime Biological Business Overview Table 135. Longtime Biological PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Longtime Biological PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 137. Longtime Biological Recent Development Table 138. WEGO Company Information Table 139. WEGO Business Overview Table 140. WEGO PRP (Platelet-Rich Plasma) Kits Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. WEGO PRP (Platelet-Rich Plasma) Kits Product Portfolio Table 142. WEGO Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. PRP (Platelet-Rich Plasma) Kits Distributors List Table 146. PRP (Platelet-Rich Plasma) Kits Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. PRP (Platelet-Rich Plasma) Kits Product Image Figure 2. Global PRP (Platelet-Rich Plasma) Kits Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PRP (Platelet-Rich Plasma) Kits Market Size (2021-2032) & (US$ Million) Figure 4. Global PRP (Platelet-Rich Plasma) Kits Sales (2021-2032) & (K Units) Figure 5. Global PRP (Platelet-Rich Plasma) Kits Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 PRP (Platelet-Rich Plasma) Kits Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Class II Medical Device Image Figure 9. Class I Medical Device Image Figure 10. Global PRP (Platelet-Rich Plasma) Kits Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Type (2021-2032) Figure 13. Global PRP (Platelet-Rich Plasma) Kits Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Type (2021-2032) Figure 16. Medical Image Figure 17. Laboratory Image Figure 18. Others Image Figure 19. Global PRP (Platelet-Rich Plasma) Kits Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Application (2021-2032) Figure 22. Global PRP (Platelet-Rich Plasma) Kits Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Application (2021-2032) Figure 25. North America PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America PRP (Platelet-Rich Plasma) Kits Sales Market Share by Country (2021-2032) Figure 27. U.S. PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe PRP (Platelet-Rich Plasma) Kits Sales Market Share by Country (2021-2032) Figure 32. Germany PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales Market Share by Country (2021-2032) Figure 39. China PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales Market Share by Country (2021-2032) Figure 47. Brazil PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile PRP (Platelet-Rich Plasma) Kits Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global PRP (Platelet-Rich Plasma) Kits Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032) & (US$ Million) Figure 58. North America PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032) & (US$ Million) Figure 60. Europe PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. PRP (Platelet-Rich Plasma) Kits Value Chain Figure 66. Manufacturing Cost Structure Figure 67. PRP (Platelet-Rich Plasma) Kits Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Class II Medical Device
  • Class I Medical Device
Applications
  • Medical
  • Laboratory
  • Others
Companies covered
  • AdvaCare Pharma
  • Companion (Enovis)
  • Dr. PRP USA
  • EmCyte
  • Enso Discoveries
  • Estar Medical
  • Fidia Farmaceutici
  • Juventix Regenerative Medical
  • Plasma Fresh
  • PRP PURE
  • Refine USA
  • Regen Lab SA
  • Beijing Hanbaihan Medical Devices
  • Beijing Chunlizhengda Medical Instruments
  • Longtime Biological
  • WEGO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PRP (Platelet-Rich Plasma) Kits Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PRP (Platelet-Rich Plasma) Kits Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global PRP (Platelet-Rich Plasma) Kits Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global PRP (Platelet-Rich Plasma) Kits Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global PRP (Platelet-Rich Plasma) Kits Market Dynamics
  1. 2.1 PRP (Platelet-Rich Plasma) Kits Industry Trends
  2. 2.2 PRP (Platelet-Rich Plasma) Kits Industry Drivers
  3. 2.3 PRP (Platelet-Rich Plasma) Kits Industry Opportunities and Challenges
  4. 2.4 PRP (Platelet-Rich Plasma) Kits Industry Restraints
3 PRP (Platelet-Rich Plasma) Kits Market by Manufacturers
  1. 3.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Manufacturers (2021-2026)
  2. 3.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Manufacturers (2021-2026)
  3. 3.3 Global PRP (Platelet-Rich Plasma) Kits Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global PRP (Platelet-Rich Plasma) Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PRP (Platelet-Rich Plasma) Kits Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global PRP (Platelet-Rich Plasma) Kits Manufacturers, Product Type & Application
  7. 3.7 Global PRP (Platelet-Rich Plasma) Kits Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PRP (Platelet-Rich Plasma) Kits Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PRP (Platelet-Rich Plasma) Kits Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PRP (Platelet-Rich Plasma) Kits Tier 1, Tier 2, and Tier 3
4 PRP (Platelet-Rich Plasma) Kits Market by Type
  1. 4.1 PRP (Platelet-Rich Plasma) Kits Type Introduction
  2. 4.1.1 Class II Medical Device
  3. 4.1.2 Class I Medical Device
  4. 4.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Type
  5. 4.2.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Type (2021-2032)
  7. 4.2.3 Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Type (2021-2032)
  8. 4.3 Global PRP (Platelet-Rich Plasma) Kits Revenue by Type
  9. 4.3.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global PRP (Platelet-Rich Plasma) Kits Revenue by Type (2021-2032)
  11. 4.3.3 Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Type (2021-2032)
5 PRP (Platelet-Rich Plasma) Kits Market by Application
  1. 5.1 PRP (Platelet-Rich Plasma) Kits Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Application
  6. 5.2.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Application (2021-2032)
  8. 5.2.3 Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Application (2021-2032)
  9. 5.3 Global PRP (Platelet-Rich Plasma) Kits Revenue by Application
  10. 5.3.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global PRP (Platelet-Rich Plasma) Kits Revenue by Application (2021-2032)
  12. 5.3.3 Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Application (2021-2032)
6 Global PRP (Platelet-Rich Plasma) Kits Sales by Region
  1. 6.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Region (2021-2032)
  3. 6.2.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Region (2021-2026)
  4. 6.2.2 Global PRP (Platelet-Rich Plasma) Kits Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region
  1. 7.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region
  2. 7.1.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region (2021-2026)
  4. 7.1.3 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region (2027-2032)
  5. 7.1.4 Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
  8. 7.2.2 North America PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
  11. 7.3.2 Europe PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AdvaCare Pharma
  2. 8.1.1 AdvaCare Pharma Company Information
  3. 8.1.2 AdvaCare Pharma Business Overview
  4. 8.1.3 AdvaCare Pharma PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AdvaCare Pharma PRP (Platelet-Rich Plasma) Kits Product Portfolio
  6. 8.1.5 AdvaCare Pharma Recent Developments
  7. 8.2 Companion (Enovis)
  8. 8.2.1 Companion (Enovis) Company Information
  9. 8.2.2 Companion (Enovis) Business Overview
  10. 8.2.3 Companion (Enovis) PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Companion (Enovis) PRP (Platelet-Rich Plasma) Kits Product Portfolio
  12. 8.2.5 Companion (Enovis) Recent Developments
  13. 8.3 Dr. PRP USA
  14. 8.3.1 Dr. PRP USA Company Information
  15. 8.3.2 Dr. PRP USA Business Overview
  16. 8.3.3 Dr. PRP USA PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr. PRP USA PRP (Platelet-Rich Plasma) Kits Product Portfolio
  18. 8.3.5 Dr. PRP USA Recent Developments
  19. 8.4 EmCyte
  20. 8.4.1 EmCyte Company Information
  21. 8.4.2 EmCyte Business Overview
  22. 8.4.3 EmCyte PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 EmCyte PRP (Platelet-Rich Plasma) Kits Product Portfolio
  24. 8.4.5 EmCyte Recent Developments
  25. 8.5 Enso Discoveries
  26. 8.5.1 Enso Discoveries Company Information
  27. 8.5.2 Enso Discoveries Business Overview
  28. 8.5.3 Enso Discoveries PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Enso Discoveries PRP (Platelet-Rich Plasma) Kits Product Portfolio
  30. 8.5.5 Enso Discoveries Recent Developments
  31. 8.6 Estar Medical
  32. 8.6.1 Estar Medical Company Information
  33. 8.6.2 Estar Medical Business Overview
  34. 8.6.3 Estar Medical PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Estar Medical PRP (Platelet-Rich Plasma) Kits Product Portfolio
  36. 8.6.5 Estar Medical Recent Developments
  37. 8.7 Fidia Farmaceutici
  38. 8.7.1 Fidia Farmaceutici Company Information
  39. 8.7.2 Fidia Farmaceutici Business Overview
  40. 8.7.3 Fidia Farmaceutici PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fidia Farmaceutici PRP (Platelet-Rich Plasma) Kits Product Portfolio
  42. 8.7.5 Fidia Farmaceutici Recent Developments
  43. 8.8 Juventix Regenerative Medical
  44. 8.8.1 Juventix Regenerative Medical Company Information
  45. 8.8.2 Juventix Regenerative Medical Business Overview
  46. 8.8.3 Juventix Regenerative Medical PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Juventix Regenerative Medical PRP (Platelet-Rich Plasma) Kits Product Portfolio
  48. 8.8.5 Juventix Regenerative Medical Recent Developments
  49. 8.9 Plasma Fresh
  50. 8.9.1 Plasma Fresh Company Information
  51. 8.9.2 Plasma Fresh Business Overview
  52. 8.9.3 Plasma Fresh PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Plasma Fresh PRP (Platelet-Rich Plasma) Kits Product Portfolio
  54. 8.9.5 Plasma Fresh Recent Developments
  55. 8.10 PRP PURE
  56. 8.10.1 PRP PURE Company Information
  57. 8.10.2 PRP PURE Business Overview
  58. 8.10.3 PRP PURE PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PRP PURE PRP (Platelet-Rich Plasma) Kits Product Portfolio
  60. 8.10.5 PRP PURE Recent Developments
  61. 8.11 Refine USA
  62. 8.11.1 Refine USA Company Information
  63. 8.11.2 Refine USA Business Overview
  64. 8.11.3 Refine USA PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Refine USA PRP (Platelet-Rich Plasma) Kits Product Portfolio
  66. 8.11.5 Refine USA Recent Developments
  67. 8.12 Regen Lab SA
  68. 8.12.1 Regen Lab SA Company Information
  69. 8.12.2 Regen Lab SA Business Overview
  70. 8.12.3 Regen Lab SA PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Regen Lab SA PRP (Platelet-Rich Plasma) Kits Product Portfolio
  72. 8.12.5 Regen Lab SA Recent Developments
  73. 8.13 Beijing Hanbaihan Medical Devices
  74. 8.13.1 Beijing Hanbaihan Medical Devices Company Information
  75. 8.13.2 Beijing Hanbaihan Medical Devices Business Overview
  76. 8.13.3 Beijing Hanbaihan Medical Devices PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Beijing Hanbaihan Medical Devices PRP (Platelet-Rich Plasma) Kits Product Portfolio
  78. 8.13.5 Beijing Hanbaihan Medical Devices Recent Developments
  79. 8.14 Beijing Chunlizhengda Medical Instruments
  80. 8.14.1 Beijing Chunlizhengda Medical Instruments Company Information
  81. 8.14.2 Beijing Chunlizhengda Medical Instruments Business Overview
  82. 8.14.3 Beijing Chunlizhengda Medical Instruments PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Beijing Chunlizhengda Medical Instruments PRP (Platelet-Rich Plasma) Kits Product Portfolio
  84. 8.14.5 Beijing Chunlizhengda Medical Instruments Recent Developments
  85. 8.15 Longtime Biological
  86. 8.15.1 Longtime Biological Company Information
  87. 8.15.2 Longtime Biological Business Overview
  88. 8.15.3 Longtime Biological PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Longtime Biological PRP (Platelet-Rich Plasma) Kits Product Portfolio
  90. 8.15.5 Longtime Biological Recent Developments
  91. 8.16 WEGO
  92. 8.16.1 WEGO Company Information
  93. 8.16.2 WEGO Business Overview
  94. 8.16.3 WEGO PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 WEGO PRP (Platelet-Rich Plasma) Kits Product Portfolio
  96. 8.16.5 WEGO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PRP (Platelet-Rich Plasma) Kits Value Chain Analysis
  2. 9.1.1 PRP (Platelet-Rich Plasma) Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PRP (Platelet-Rich Plasma) Kits Production Mode & Process
  6. 9.2 PRP (Platelet-Rich Plasma) Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PRP (Platelet-Rich Plasma) Kits Distributors
  9. 9.2.3 PRP (Platelet-Rich Plasma) Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research